“…Nineteen different interventions were used in the retrieved studies in total. Specified diagnoses were: craniopharyngioma (n=564, 74%), [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32] medulloblastoma (n=94, 12%), 23,33,34 primary neuroectodermal tumour (n=10, 1%), 33,34 unspecified brain tumour (n=44, 6%), [35][36][37][38][39] unspecified brain trauma (n=2, 0.3%), 40 meningitis (n=1, 0.1%), 16 structural hypothalamic lesions (n=12, 2%), 41 astrocytoma (n=9, 1%), 22,23 germinioma (n=6, 0.8%), 22,23,26 optic pathway glioma (n=2, 0.3%), 22,39 lipoma (n=1, 0.1%), 26 hamartoma (n=1, 0.1%), 26 germ cell tumour (n=1, 0.1%), 42 and glioma (n=1, 0.1%). 26 In 11 cases (1%), patients could not be disaggregated from the sample by diagnosis.…”